APNHY (Aspen Pharmacare Holdings) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

APNHY Aspen Pharmacare Holdings Ltd APNHY
73 GF Score
Price $8.89
GF Value $10.03
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Aspen Pharmacare Holdings Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

APNHY
73GF Score
Aspen Pharmacare Holdings Ltd APNHY
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Aspen Pharmacare Holdings (APNHY) Overvalued in 2026?

Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued. The current stock price of $8.89 is trading 11.4% below its estimated GF Value™ of $10.03. GuruFocus considers Aspen Pharmacare Holdings to be Modestly Undervalued.

Key valuation signals for APNHY:

  • Dividends Received:
  • GF Value™: $10.03 vs. price of $8.89 (11.4% below fair value)
  • GF Score™: 73/100 with 10 warning signs

No single metric tells the full story. See the APNHY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aspen Pharmacare Holdings Business Description

Address Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
73GF Score

Get the complete analysis for APNHY

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.89
Price
$10.03
GF Value